Location History:
- Lausanne, CH (2010 - 2018)
- Neuchatel, CH (2013 - 2019)
Company Filing History:
11 out of 694 
2 out of 1,289 
1 out of 336 
Years Active: 2010-2019
Title: Innovations of Kai Peter Johnsson
Introduction
Kai Peter Johnsson is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the detection of important cofactors. With a total of 14 patents to his name, his work has implications in various scientific and medical applications.
Latest Patents
One of his latest patents focuses on sensors, methods, and kits for detecting nicotinamide adenine dinucleotides. This invention relates to the in vitro and in cellulo detection of the cofactors nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). The sensor molecule he developed allows for fluorescence- or luminescence-based detection of these analytes, particularly for measuring the concentrations of NAD, NADP, and their ratios. Another significant patent involves sepiapterin reductase inhibitors, which are useful in analgesia, treatment of acute and chronic pain, anti-inflammation, and immune cell regulation.
Career Highlights
Throughout his career, Johnsson has worked with prestigious institutions such as École Polytechnique Fédérale de Lausanne and the Max Planck Society for the Advancement of Science. His research has been pivotal in advancing our understanding of biochemical processes and developing innovative detection methods.
Collaborations
Johnsson has collaborated with notable colleagues, including Maik Kindermann and Antje Keppler, who have contributed to his research endeavors.
Conclusion
Kai Peter Johnsson's innovative work in the field of biochemistry has led to significant advancements in the detection of vital cofactors. His contributions continue to influence research and applications in various scientific domains.